Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for rare uterine cancer? trial tests avastin with chemo

NCT ID NCT01012297

Disease control Sponsor: National Cancer Institute (NCI) Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This phase 3 trial tested whether adding bevacizumab (Avastin) to standard chemotherapy (docetaxel and gemcitabine) helps people with advanced or recurrent uterine leiomyosarcoma. The study enrolled 107 participants but was terminated early. Researchers measured how long patients lived without the cancer growing (progression-free survival) and overall survival. The goal was to see if the drug combo works better than chemo alone.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Bevacizumab (Avastin) added to chemotherapy (docetaxel and gemcitabine)
What this could lead to
If it works, adding bevacizumab could help slow tumor growth or improve survival for people with advanced uterine leiomyosarcoma.
What could go wrong
The trial was terminated early with only 107 participants, so results are limited. Bevacizumab may not improve outcomes and can cause side effects like bleeding or high blood pressure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

107 people

The number who actually took part.

Start date

Nov 2009

Finished

Sep 2015

Lead sponsor

A government research agency

The lead sponsor is the US National Institutes of Health.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients must have advanced or recurrent uterine leiomyosarcoma with documented disease progression; histologic confirmation of the original primary tumor is required * All patients must have measurable disease as defined by RECIST 1.1; measurable disease is defined as at least one lesion that can be accurately measured in at least one dimension (longest diameter to be recorded); each lesion must be \>= 10 mm when measured by CT, MRI or caliper measurement by clinical exam; or \>= 20 mm when measured by chest x-ray; lymph nodes must be \>= 15 mm in short axis when measured by CT or MRI * Patient must have at least one "target lesion" to be used to assess response on this protocol as defined by RECIST 1.1; tumors within a previously irradiated field will be designated as "non-target" lesions unless progression is documented or a biopsy is obtained to confirm persistence at least 90 days following completion of radiation therapy * Patients must have a GOG Performance Status of 0, 1, or 2 * Patients must have recovered from effects of recent surgery, radiotherapy or other therapy * Patients should be free of active infection requiring antibiotics (with the exception of an uncomplicated UTI) * Any hormonal therapy directed at the malignant tumor must be discontinued at least one week prior to first day of study treatment; continuation of hormone replacement therapy is permitted * Platelet count greater than or equal to 100,000/mm\^3 * ANC count greater than or equal to 1,500/mm\^3 * Creatinine less than or equal to 1.5 x institutional upper limit normal (ULN), per NCI CTCAE Version 4.0 Grade 1 * Bilirubin within normal range (CTCAE Version 4 Grade 0) * SGOT and alkaline phosphatase less than or equal to 2.5 x ULN, per the CTCAE Version 4.0 Grade 1) * SGOT less than or equal to 2.5 x ULN, per the CTCAE Version 4.0 Grade 1 * Alkaline phosphatase less than or equal to 2.5 x ULN, per the CTCAE Version 4.0 Grade 1 * Neuropathy (sensory and motor) less than or equal to Grade 1 per the CTCAE Version 4.0. * No history of transient ischemic attack (TIA) or stroke or CNS hemorrhage within the past 6 months * Urine protein creatinine (UPC) ratio must be \< 1.0 gm; if UPC ratio \>= 1, collection of 24-hour urine measurement of urine protein is recommended * PT such that international normalized ratio (INR) is =\< 1.5 and a PTT =\< 1.5 times the institutional upper limit of normal (or an in-therapeutic-range INR, usually between 2 and 3, if a patient is on a stable dose of therapeutic warfarin) * Patients must have signed an approved informed consent and authorization permitting release of personal health information * Patients must meet pre-entry requirements * Patients of childbearing potential must have a negative serum pregnancy test prior to the study entry and be practicing an effective form of contraception Exclusion Criteria: * Patients who have received prior cytotoxic chemotherapy for management of uterine sarcoma; patients who have received prior VEGF-pathway targeted agent such as bevacizumab, PTK787, VEGF-trap, or who have received prior treatment with a multi-kinase inhibitor such as sorafenib or sunitinib are not eligible * Patients who have had prior therapy with docetaxel or gemcitabine or bevacizumab * Patients with a history of other invasive malignancies, with the exceptions of non-melanoma skin cancer, carcinoma in situ of the cervix, and ductal carcinoma in situ of the breast, are excluded if there is any evidence of other malignancy being present within the last five years; patients are also excluded if their previous cancer treatment contraindicates this protocol therapy * Patients with active bleeding or pathologic conditions that carry high risk of bleeding, such as known bleeding disorder, coagulopathy, or tumor involving major vessels; (necessary use of warfarin or low molecular weight heparin is permitted, provided the INR is maintained in the therapeutic range of approximately 2-3) * Patients with major surgery or significant traumatic injury within 28 days prior to study entry * Patients with a history of abdominal fistula or perforation within the past 12 months * Patients with a current, serious, non-healing wound, ulcer, or bone fracture * Patients with history or evidence upon physical examination of CNS disease, including history of primary brain tumor, or any history of brain metastases, or seizures not controlled with standard medical therapy * Patients with known hypersensitivity to Chinese hamster ovary cell products or other recombinant human or humanized antibodies * Cardiovascular function; specifically, patient may not have: * Uncontrolled hypertension, defined as systolic \> 150 mm Hg or diastolic \> 100 mm Hg in a patient with no history of hypertension; patients with a history of hypertension before enrollment on study are permitted, but such patients must have BP less than or equal to 140/90 mmHg; use of blood pressure medications to achieve and maintain blood pressure control is permitted * Myocardial infarction or unstable angina within 6 months of the first date of bevacizumab/placebo therapy * New York Heart Association (NYHA) Grade II or greater congestive heart failure or serious cardiac arrhythmia requiring medication; women who have received prior treatment with an anthracycline (including doxorubicin and/or liposomal doxorubicin) and have an ejection fraction \< 50% will be excluded from the study * Grade 1, Category 2 or greater, peripheral vascular disease; patient cannot have anything worse than mild, symptomatic claudication with exercise * History of cerebrovascular accident (CVA, stroke), transient ischemic attack (TIA) or subarachnoid hemorrhage within six months of the first date of bevacizumab/placebo therapy * History of pulmonary embolism or deep vein thrombosis in the past 6 months * Patients with, or with anticipation of, invasive procedures as defined below: * Major surgical procedure, open biopsy or significant traumatic injury within 28 days prior to the first date of bevacizumab/placebo therapy * Major surgical procedure anticipated during the course of the study. * Minor surgical procedures (i.e., mediport insertion), fine needle aspirates, or core biopsies within 7 days prior to the first date of bevacizumab/placebo therapy * Patients who are pregnant or nursing

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Recurrent uterine corpus sarcoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

leiomyosarcoma of the corpus uteri uterine corpus sarcoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Recurrent uterine corpus sarcoma Stage IIIA uterine sarcoma Stage IIIB uterine sarcoma Stage IIIC uterine sarcoma Stage IVA uterine sarcoma Stage IVB uterine sarcoma Uterine corpus leiomyosarcoma

Contacts and locations

Locations

  • Abbott-Northwestern Hospital

    Minneapolis, Minnesota, 55407, United States

  • Abington Memorial Hospital

    Abington, Pennsylvania, 19001, United States

  • Avera Cancer Institute

    Sioux Falls, South Dakota, 57105, United States

  • Baptist Health Lexington

    Lexington, Kentucky, 40503, United States

  • Baylor All Saints Medical Center at Fort Worth

    Fort Worth, Texas, 76104, United States

  • Beebe Medical Center

    Lewes, Delaware, 19958, United States

  • Borgess Medical Center

    Kalamazoo, Michigan, 49001, United States

  • Boulder Community Hospital

    Boulder, Colorado, 80301, United States

  • Bronson Battle Creek

    Battle Creek, Michigan, 49017, United States

  • Bronson Methodist Hospital

    Kalamazoo, Michigan, 49007, United States

  • Cadence Cancer Center in Warrenville

    Warrenville, Illinois, 60555, United States

  • Cancer Center of Western Wisconsin

    New Richmond, Wisconsin, 54017, United States

  • Cancer Research for the Ozarks NCORP

    Springfield, Missouri, 65804, United States

  • Carolinas HealthCare System NorthEast

    Concord, North Carolina, 28025, United States

  • Carolinas Medical Center/Levine Cancer Institute

    Charlotte, North Carolina, 28203, United States

  • Case Western Reserve University

    Cleveland, Ohio, 44106, United States

  • Center of Hope at Renown Medical Center

    Reno, Nevada, 89502, United States

  • Christiana Care Health System-Christiana Hospital

    Newark, Delaware, 19718, United States

  • Clements University Hospital

    Dallas, Texas, 75390, United States

  • Cleveland Clinic Cancer Center/Fairview Hospital

    Cleveland, Ohio, 44111, United States

  • Cleveland Clinic Foundation

    Cleveland, Ohio, 44195, United States

  • Colorado Cancer Research Program CCOP

    Denver, Colorado, 80224-2522, United States

  • Community Howard Regional Health

    Kokomo, Indiana, 46904, United States

  • Cooper Hospital University Medical Center

    Camden, New Jersey, 08103, United States

  • CoxHealth South Hospital

    Springfield, Missouri, 65807, United States

  • Dartmouth Hitchcock Medical Center

    Lebanon, New Hampshire, 03756, United States

  • Duke University Medical Center

    Durham, North Carolina, 27710, United States

  • Elkhart Clinic

    Elkhart, Indiana, 46514-2098, United States

  • Elkhart General Hospital

    Elkhart, Indiana, 46515, United States

  • Exempla Saint Joseph Hospital

    Denver, Colorado, 80218, United States

  • Fairview Ridges Hospital

    Burnsville, Minnesota, 55337, United States

  • Fairview-Southdale Hospital

    Edina, Minnesota, 55435, United States

  • Florida Hospital Orlando

    Orlando, Florida, 32803, United States

  • Fox Chase Cancer Center

    Philadelphia, Pennsylvania, 19111, United States

  • Franciscan Saint Francis Health-Indianapolis

    Indianapolis, Indiana, 46237, United States

  • Geisinger Medical Center

    Danville, Pennsylvania, 17822, United States

  • Geisinger Medical Center-Cancer Center Hazleton

    Hazleton, Pennsylvania, 18201, United States

  • Geisinger Medical Group

    State College, Pennsylvania, 16801, United States

  • Geisinger Wyoming Valley/Henry Cancer Center

    Wilkes-Barre, Pennsylvania, 18711, United States

  • Georgia Regents University Medical Center

    Augusta, Georgia, 30912, United States

  • Grand Rapids Clinical Oncology Program

    Grand Rapids, Michigan, 49503, United States

  • Greater Baltimore Medical Center

    Baltimore, Maryland, 21204, United States

  • Gynecologic Oncology of Indiana

    Indianapolis, Indiana, 46237, United States

  • Hartford Hospital

    Hartford, Connecticut, 06102, United States

  • Hennepin County Medical Center

    Minneapolis, Minnesota, 55415, United States

  • Hillcrest Hospital Cancer Center

    Mayfield Heights, Ohio, 44124, United States

  • Huntsman Cancer Institute/University of Utah

    Salt Lake City, Utah, 84112, United States

  • Hutchinson Area Health Care

    Hutchinson, Minnesota, 55350, United States

  • IU Health La Porte Hospital

    La Porte, Indiana, 46350, United States

  • Indiana University/Melvin and Bren Simon Cancer Center

    Indianapolis, Indiana, 46202, United States

  • Iowa Lutheran Hospital

    Des Moines, Iowa, 50316, United States

  • Iowa Methodist Medical Center

    Des Moines, Iowa, 50309, United States

  • Iowa Oncology Research Association CCOP

    Des Moines, Iowa, 50309, United States

  • John B Amos Cancer Center

    Columbus, Georgia, 31904, United States

  • John Muir Medical Center-Concord Campus

    Concord, California, 94520, United States

  • John Muir Medical Center-Walnut Creek

    Walnut Creek, California, 94598, United States

  • Johns Hopkins University/Sidney Kimmel Cancer Center

    Baltimore, Maryland, 21287, United States

  • Kaiser Permanente Los Angeles Medical Center

    Los Angeles, California, 90027, United States

  • Kettering Medical Center

    Kettering, Ohio, 45429, United States

  • Lahey Hospital and Medical Center

    Burlington, Massachusetts, 01805, United States

  • Lake University Ireland Cancer Center

    Mentor, Ohio, 44060, United States

  • Lakeland Hospital

    Saint Joseph, Michigan, 49085, United States

  • Lakeview Hospital

    Stillwater, Minnesota, 55082, United States

  • Lehigh Valley Hospital-Cedar Crest

    Allentown, Pennsylvania, 18103, United States

  • Littleton Adventist Hospital

    Littleton, Colorado, 80122, United States

  • Longmont United Hospital

    Longmont, Colorado, 80501, United States

  • Los Angeles County-USC Medical Center

    Los Angeles, California, 90033, United States

  • M D Anderson Cancer Center

    Houston, Texas, 77030, United States

  • Marie Yeager Cancer Center

    Saint Joseph, Michigan, 49085, United States

  • Mayo Clinic

    Rochester, Minnesota, 55905, United States

  • Mayo Clinic in Florida

    Jacksonville, Florida, 32224-9980, United States

  • McKee Medical Center

    Loveland, Colorado, 80539, United States

  • MedStar Franklin Square Medical Center/Weinberg Cancer Institute

    Baltimore, Maryland, 21237, United States

  • Medical Oncology and Hematology Associates-Des Moines

    Des Moines, Iowa, 50309, United States

  • Medical Oncology and Hematology Associates-Laurel

    Des Moines, Iowa, 50314, United States

  • Medical Oncology and Hematology Associates-West Des Moines

    Clive, Iowa, 50325, United States

  • Medical University of South Carolina

    Charleston, South Carolina, 29425, United States

  • Memorial Hospital of South Bend

    South Bend, Indiana, 46601, United States

  • Memorial Medical Center

    Springfield, Illinois, 62781, United States

  • Memorial Medical Center - Las Cruces

    Las Cruces, New Mexico, 88011, United States

  • Memorial Sloan-Kettering Cancer Center

    New York, New York, 10065, United States

  • Memorial University Medical Center

    Savannah, Georgia, 31404, United States

  • Mercy Cancer Center-West Lakes

    Clive, Iowa, 50325, United States

  • Mercy Health Mercy Campus

    Muskegon, Michigan, 49444, United States

  • Mercy Health Saint Mary's

    Grand Rapids, Michigan, 49503, United States

  • Mercy Hospital

    Miami, Florida, 33133, United States

  • Mercy Hospital

    Coon Rapids, Minnesota, 55433, United States

  • Mercy Hospital Springfield

    Springfield, Missouri, 65804, United States

  • Mercy Medical Center - Des Moines

    Des Moines, Iowa, 50314, United States

  • Mercy Medical Center-West Lakes

    West Des Moines, Iowa, 50266, United States

  • Methodist West Hospital

    West Des Moines, Iowa, 50266-7700, United States

  • Metro Health Hospital

    Wyoming, Michigan, 49519, United States

  • Metro-Minnesota NCI Community Oncology Research Program

    Saint Louis Park, Minnesota, 55416, United States

  • MetroHealth Medical Center

    Cleveland, Ohio, 44109, United States

  • Michiana Hematology Oncology PC-Elkhart

    Elkhart, Indiana, 46514, United States

  • Michiana Hematology Oncology PC-Mishawaka

    Mishawaka, Indiana, 46545, United States

  • Michiana Hematology Oncology PC-Niles

    Niles, Michigan, 49120, United States

  • Michiana Hematology Oncology PC-Plymouth

    Plymouth, Indiana, 46563, United States

  • Michiana Hematology Oncology PC-South Bend

    South Bend, Indiana, 46601, United States

  • Michiana Hematology Oncology PC-Westville

    Westville, Indiana, 46391, United States

  • Minnesota Oncology Hematology PA-Maplewood

    Maplewood, Minnesota, 55109, United States

  • Minnesota Oncology and Hematology PA-Woodbury

    Woodbury, Minnesota, 55125, United States

  • Morristown Medical Center

    Morristown, New Jersey, 07960, United States

  • Mount Sinai Medical Center

    New York, New York, 10029, United States

  • Munson Medical Center

    Traverse City, Michigan, 49684, United States

  • Nebraska Methodist Hospital

    Omaha, Nebraska, 68114, United States

  • New Ulm Medical Center

    New Ulm, Minnesota, 56073, United States

  • North Colorado Medical Center

    Greeley, Colorado, 80631, United States

  • North Memorial Medical Health Center

    Robbinsdale, Minnesota, 55422, United States

  • North Suburban Medical Center

    Thornton, Colorado, 80229, United States

  • Northern Indiana Cancer Research Consortium CCOP

    South Bend, Indiana, 46628, United States

  • Northwestern University

    Chicago, Illinois, 60611, United States

  • Norton Hospital Pavilion and Medical Campus

    Louisville, Kentucky, 40202, United States

  • Novant Health Presbyterian Medical Center

    Charlotte, North Carolina, 28204, United States

  • Ohio State University Comprehensive Cancer Center

    Columbus, Ohio, 43210, United States

  • Olive View-University of California Los Angeles Medical Center

    Sylmar, California, 91342, United States

  • Overlook Hospital

    Summit, New Jersey, 07902, United States

  • Palo Alto Medical Foundation-Gynecologic Oncology

    Mountain View, California, 94040, United States

  • Park Nicollet Clinic - Saint Louis Park

    Saint Louis Park, Minnesota, 55416, United States

  • Parker Adventist Hospital

    Parker, Colorado, 80138, United States

  • Parkland Memorial Hospital

    Dallas, Texas, 75235, United States

  • Penn State Milton S Hershey Medical Center

    Hershey, Pennsylvania, 17033-0850, United States

  • Pennsylvania Hospital

    Philadelphia, Pennsylvania, 19107, United States

  • Penrose-Saint Francis Healthcare

    Colorado Springs, Colorado, 80907, United States

  • Porter Adventist Hospital

    Denver, Colorado, 80210, United States

  • Presbyterian - Saint Lukes Medical Center - Health One

    Denver, Colorado, 80218, United States

  • Providence Saint Joseph Medical Center/Disney Family Cancer Center

    Burbank, California, 91505, United States

  • Reading Hospital

    West Reading, Pennsylvania, 19611, United States

  • Regions Hospital

    Saint Paul, Minnesota, 55101, United States

  • Rice Memorial Hospital

    Willmar, Minnesota, 56201, United States

  • Ridgeview Medical Center

    Waconia, Minnesota, 55387, United States

  • Riverside Methodist Hospital

    Columbus, Ohio, 43214, United States

  • Rocky Mountain Gynecologic Oncology PC

    Englewood, Colorado, 80110, United States

  • Rose Medical Center

    Denver, Colorado, 80220, United States

  • Rush University Medical Center

    Chicago, Illinois, 60612, United States

  • Rutgers Cancer Institute of New Jersey

    New Brunswick, New Jersey, 08903, United States

  • SCL Health Lutheran Medical Center

    Wheat Ridge, Colorado, 80033, United States

  • Saint Anthony Hospital

    Lakewood, Colorado, 80228, United States

  • Saint Francis Regional Medical Center

    Shakopee, Minnesota, 55379, United States

  • Saint John's Hospital - Healtheast

    Maplewood, Minnesota, 55109, United States

  • Saint Joseph Regional Medical Center-Mishawaka

    Mishawaka, Indiana, 46545, United States

  • Saint Joseph's Hospital and Medical Center

    Phoenix, Arizona, 85013, United States

  • Saint Mary Corwin Medical Center

    Pueblo, Colorado, 81004, United States

  • Saint Mary's Hospital and Regional Medical Center

    Grand Junction, Colorado, 81502, United States

  • Saint Vincent Oncology Center

    Indianapolis, Indiana, 46260, United States

  • Sanford Cancer Center-Oncology Clinic

    Sioux Falls, South Dakota, 57104, United States

  • Sanford USD Medical Center - Sioux Falls

    Sioux Falls, South Dakota, 57117-5134, United States

  • Sky Ridge Medical Center

    Lone Tree, Colorado, 80124, United States

  • South Bend Clinic

    South Bend, Indiana, 46617, United States

  • Southwest Gynecologic Oncology Associates Inc

    Albuquerque, New Mexico, 87106, United States

  • Spectrum Health Big Rapids Hospital

    Big Rapids, Michigan, 49307, United States

  • Spectrum Health Reed City Hospital

    Reed City, Michigan, 49677, United States

  • Spectrum Health at Butterworth Campus

    Grand Rapids, Michigan, 49503, United States

  • State University of New York Downstate Medical Center

    Brooklyn, New York, 11203, United States

  • Stony Brook University Medical Center

    Stony Brook, New York, 11794, United States

  • Sudarshan K Sharma MD Limted-Gynecologic Oncology

    Hinsdale, Illinois, 60521, United States

  • Summa Akron City Hospital/Cooper Cancer Center

    Akron, Ohio, 44304, United States

  • Swedish Medical Center

    Englewood, Colorado, 80113, United States

  • The Hospital of Central Connecticut

    New Britain, Connecticut, 06050, United States

  • The James Graham Brown Cancer Center at University of Louisville

    Louisville, Kentucky, 40202, United States

  • The Medical Center of Aurora

    Aurora, Colorado, 80012, United States

  • Tulsa Cancer Institute

    Tulsa, Oklahoma, 74146, United States

  • UC Irvine Health/Chao Family Comprehensive Cancer Center

    Orange, California, 92868, United States

  • UC San Diego Moores Cancer Center

    La Jolla, California, 92093, United States

  • UCLA / Jonsson Comprehensive Cancer Center

    Los Angeles, California, 90095, United States

  • UCSF Medical Center-Mount Zion

    San Francisco, California, 94115, United States

  • UF Cancer Center at Orlando Health

    Orlando, Florida, 32806, United States

  • UMDNJ - Robert Wood Johnson University Hospital

    New Brunswick, New Jersey, 08903, United States

  • UPMC-Magee Womens Hospital

    Pittsburgh, Pennsylvania, 15213, United States

  • USC / Norris Comprehensive Cancer Center

    Los Angeles, California, 90033, United States

  • UT Southwestern/Simmons Cancer Center-Dallas

    Dallas, Texas, 75390, United States

  • Union Hospital of Cecil County

    Elkton, Maryland, 21921, United States

  • United Hospital

    Saint Paul, Minnesota, 55102, United States

  • Unity Hospital

    Fridley, Minnesota, 55432, United States

  • University of California San Diego

    San Diego, California, 92103, United States

  • University of Chicago Comprehensive Cancer Center

    Chicago, Illinois, 60637, United States

  • University of Cincinnati

    Cincinnati, Ohio, 45267, United States

  • University of Colorado Cancer Center - Anschutz Cancer Pavilion

    Aurora, Colorado, 80045, United States

  • University of Iowa/Holden Comprehensive Cancer Center

    Iowa City, Iowa, 52242, United States

  • University of Kansas Cancer Center

    Kansas City, Kansas, 66160, United States

  • University of Maryland/Greenebaum Cancer Center

    Baltimore, Maryland, 21201, United States

  • University of Miami Miller School of Medicine-Sylvester Cancer Center

    Miami, Florida, 33136, United States

  • University of Mississippi Medical Center

    Jackson, Mississippi, 39216, United States

  • University of New Mexico

    Albuquerque, New Mexico, 87102, United States

  • University of New Mexico Cancer Center

    Albuquerque, New Mexico, 87106, United States

  • University of Oklahoma Health Sciences Center

    Oklahoma City, Oklahoma, 73104, United States

  • University of Vermont Medical Center

    Burlington, Vermont, 05401, United States

  • University of Wisconsin Hospital and Clinics

    Madison, Wisconsin, 53792, United States

  • Virtua Memorial

    Mount Holly, New Jersey, 08060, United States

  • Virtua West Jersey Hospital Voorhees

    Voorhees Township, New Jersey, 08043, United States

  • Wake Forest University Health Sciences

    Winston-Salem, North Carolina, 27157, United States

  • Walter Reed National Military Medical Center

    Bethesda, Maryland, 20889-5600, United States

  • Washington Hospital Center

    Washington D.C., District of Columbia, 20010, United States

  • Washington University School of Medicine

    St Louis, Missouri, 63110, United States

  • Wayne State University/Karmanos Cancer Institute

    Detroit, Michigan, 48201, United States

  • West Michigan Cancer Center

    Kalamazoo, Michigan, 49007, United States

  • West Penn Hospital

    Pittsburgh, Pennsylvania, 15224, United States

  • Women and Infants Hospital

    Providence, Rhode Island, 02905, United States

  • Women's Cancer Care Associates LLC

    Albany, New York, 12208, United States

  • Women's Cancer Center of Nevada

    Las Vegas, Nevada, 89169, United States

  • Zale Lipshy University Hospital

    Dallas, Texas, 75235, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.